Today, the cancer vaccines are making very promising successes in the prophylaxis and treatment of tumors. This is why the demand of anticancer vaccines in the tumor treatment or in the cancer treatment is increasingly high.

Among the others, the anticancer vaccine - RESAN has shown an amazing results in fighting against cancer - from prophylaxis of tumors up to the absolute cure of cancer. The best results have been noticed when used rationally in combination with surgical resection of tumors, thyroxine and gamma interferon.

The cancer vaccine switches on the specific antitumoral immune system which leads to an absolute cure of cancers. The revaccinations are carried out (first one after 0.5 year and then in every 3-5 years successively) to maintain the acquired anticancer immunity.

The drug can be used as an immunotherapy of cancers: adenocarcinoma, adenocystoma, undifferentiated cancer, sarcoma, neurofibroxanthoma, fibroxanthoma, chondrosarcoma, osteosarcoma, lymphosarcoma, reticulosarcoma, carcinoma, carcinosarcoma; adenoma prostate as well as mastopathy.

In the immunotherapy of cancers, the vaccine is most effective as an antimetastatic drug: especially when used in combination with the surgical treatment of cancers - resection of primary tumor.

A complex immunotherapy is prescribed for the treatment of advanced cancers, especially if the cancer has grown up to the III and IV stages, which includes: the maximum resection of the primary tumor and visible metastases, use of anti-cancer vaccine, use of cytokines, use of thyroid hormones. Among the cytokines the IL-2 and interferon-gamma are used during the complex treatment of the advanced cancers.

The other important moment is that the cancer vaccine - Resan, working as the imitators of tumor antigens, prevents recurrences after the surgical treatment of cancers (malignant tumours) and increases the average life expectancy of patients with late stage cancers.

This anticancer vaccine also prevents malignancy and avoids surgical treatment in a number of cases of benign tumors.

For the further informations..., please choose your language and enter to our Main Page: